GoodRx Holdings (GDRX) Other Accumulated Expenses (2019 - 2023)

GoodRx Holdings (GDRX) has 5 years of Other Accumulated Expenses data on file, last reported at $8.5 million in Q1 2023.

• For the quarter ending Q1 2023, Other Accumulated Expenses rose 77.36% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2023 stood at $8.5 million (up 77.36% YoY), and the FY2022 full-year result was $6.9 million, up 58.98% from the prior year.
• Other Accumulated Expenses grew to $8.5 million in Q1 2023, from $6.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $11.4 million in Q3 2022 to a low of $1.9 million in Q4 2019.
• A 5-year average of $5.9 million and a median of $5.2 million in 2021 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 278.91% in 2020 and slumped 39.64% in 2021, its largest moves.
• Tracing GDRX's Other Accumulated Expenses over 5 years: stood at $1.9 million in 2019, then soared by 278.91% to $7.2 million in 2020, then tumbled by 39.64% to $4.3 million in 2021, then jumped by 58.98% to $6.9 million in 2022, then grew by 23.44% to $8.5 million in 2023.
• Business Quant data shows GDRX's Other Accumulated Expenses at $8.5 million in Q1 2023, $6.9 million in Q4 2022, and $11.4 million in Q3 2022.